Het gebruik van partydrugs onder jongvolwassenen in Nederland is veelvoorkomend en gaat soms gepaard met ernstige incidenten. Voor effectieve voorlichtingis het van belang te weten wat de risicopopulaties zijn en in hoeverre gebruikers zich bewust zijn van de specifieke risico’s van verschillende partydrugs. Met een schriftelijke enquête onder 514 studenten hebben de auteurs de prevalentie van partydrugsgebruik en het kennisniveau hieromtrent binnen de (Nederlandse en internationale) Groningse studentenpopulatie in kaart gebracht. Het gebruik is hoog: 30,8% van de Nederlandse studenten en 19,8% van de internationalestudenten heeft recentelijk partydrugs gebruikt, waarbij XTC het meestgebruikte middel is. Leden van studentenverenigingen gebruiken aanzienlijkmeer dan niet-leden. Het kennisniveau van de Nederlandse studenten ligt overhet algemeen hoger dan dat van de internationale studenten. De risico’s vanhet combineren van XTC met amfetamine, uppers met downers worden onderschat,evenals die van het combineren van partydrugs met alcohol. Ook weeteen groot deel van de gebruikers niet dat cocaïne en heroïne op elkaar kunnenlijken. Overige kennislacunes, preventiemaatregelen en de implicaties voordrugsvoorlichting en -preventie worden tevens in dit artikel besproken.
LINK
At its core, raving has existed in opposition to normativity, and so has electronic music. If newcomers enticed by hard trance remixes of 2000’s Top 40 hits embrace this opposition, it is often done in ways removed from history. As Loren Granic AKA Goddollars, co-founder and resident of A Club Called Rhonda in Los Angeles, stated: “Many of the newcomers are straight/white kids who are very far removed from the LGBT community, despite fist-pumping by the millions to a music that was born from gay people of colour sweating their asses off at 5 AM in a Chicago warehouse.” If the role marginalized people have played in the creation and pioneering of their favourite music is ignored, how would people react when told that their fun might also harm marginalized groups? The ethics of lockdown raves have always been fraught, as their repercussions reverberate beyond the people who choose to attend them; meanwhile, data shows that people of colour were more likely to be targeted for attending raves during the lockdown.
LINK
In this proposal, a consortium of knowledge institutes (wo, hbo) and industry aims to carry out the chemical re/upcycling of polyamides and polyurethanes by means of an ammonolysis, a depolymerisation reaction using ammonia (NH3). The products obtained are then purified from impurities and by-products, and in the case of polyurethanes, the amines obtained are reused for resynthesis of the polymer. In the depolymerisation of polyamides, the purified amides are converted to the corresponding amines by (in situ) hydrogenation or a Hofmann rearrangement, thereby forming new sources of amine. Alternatively, the amides are hydrolysed toward the corresponding carboxylic acids and reused in the repolymerisation towards polyamides. The above cycles are particularly suitable for end-of-life plastic streams from sorting installations that are not suitable for mechanical/chemical recycling. Any loss of material is compensated for by synthesis of amines from (mixtures of) end-of-life plastics and biomass (organic waste streams) and from end-of-life polyesters (ammonolysis). The ammonia required for depolymerisation can be synthesised from green hydrogen (Haber-Bosch process).By closing carbon cycles (high carbon efficiency) and supplementing the amines needed for the chain from biomass and end-of-life plastics, a significant CO2 saving is achieved as well as reduction in material input and waste. The research will focus on a number of specific industrially relevant cases/chains and will result in economically, ecologically (including safety) and socially acceptable routes for recycling polyamides and polyurethanes. Commercialisation of the results obtained are foreseen by the companies involved (a.o. Teijin and Covestro). Furthermore, as our project will result in a wide variety of new and drop-in (di)amines from sustainable sources, it will increase the attractiveness to use these sustainable monomers for currently prepared and new polyamides and polyurethanes. Also other market applications (pharma, fine chemicals, coatings, electronics, etc.) are foreseen for the sustainable amines synthesized within our proposition.
Biotherapeutic medicines such as peptides, recombinant proteins, and monoclonal antibodies have successfully entered the market for treating or providing protection against chronic and life-threatening diseases. The number of relevant commercial products is rapidly increasing. Due to degradation in the gastro-intestinal tract, protein-based drugs cannot be taken orally but need to be administered via alternative routes. The parenteral injection is still the most widely applied administration route but therapy compliance of injection-based pharmacotherapies is a concern. Long-acting injectable (LAI) sustained release dosage forms such as microparticles allow less frequent injection to maintain plasma levels within their therapeutic window. Spider Silk Protein and Poly Lactic-co-Glycolic Acid (PLGA) have been attractive candidates to fabricate devices for drug delivery applications. However, conventional microencapsulation processes to manufacture microparticles encounter drawbacks such as protein activity loss, unacceptable residual organic solvents, complex processing, and difficult scale-up. Supercritical fluids (SCF), such as supercritical carbon dioxide (scCO2), have been used to produce protein-loaded microparticles and is advantageous over conventional methods regarding adjustable fluid properties, mild operating conditions, interfacial tensionless, cheap, non-toxicity, easy downstream processing and environment-friendly. Supercritical microfluidics (SCMF) depict the idea to combine strengths of process scale reduction with unique properties of SCF. Concerning the development of long-acting microparticles for biological therapeutics, SCMF processing offers several benefits over conventionally larger-scale systems such as enhanced control on fluid flow and other critical processing parameters such as pressure and temperature, easy modulation of product properties (such as particle size, morphology, and composition), cheaper equipment build-up, and convenient parallelization for high-throughput production. The objective of this project is to develop a mild microfluidic scCO2 based process for the production of long-acting injectable protein-loaded microparticles with, for example, Spider Silk Protein or PLGA as the encapsulating materials, and to evaluate the techno-economic potential of such SCMF technology for practical & industrial production.
Biotherapeutic medicines such as peptides, recombinant proteins, and monoclonal antibodies have successfully entered the market for treating or providing protection against chronic and life-threatening diseases. The number of relevant commercial products is rapidly increasing. Due to degradation in the gastro-intestinal tract, protein-based drugs cannot be taken orally but need to be administered via alternative routes. The parenteral injection is still the most widely applied administration route but therapy compliance of injection-based pharmacotherapies is a concern. Long-acting injectable (LAI) sustained release dosage forms such as microparticles allow less frequent injection to maintain plasma levels within their therapeutic window. Spider Silk Protein and Poly Lactic-co-Glycolic Acid (PLGA) have been attractive candidates to fabricate devices for drug delivery applications. However, conventional microencapsulation processes to manufacture microparticles encounter drawbacks such as protein activity loss, unacceptable residual organic solvents, complex processing, and difficult scale-up. Supercritical fluids (SCF), such as supercritical carbon dioxide (scCO2), have been used to produce protein-loaded microparticles and is advantageous over conventional methods regarding adjustable fluid properties, mild operating conditions, interfacial tensionless, cheap, non-toxicity, easy downstream processing and environment-friendly. Supercritical microfluidics (SCMF) depict the idea to combine strengths of process scale reduction with unique properties of SCF. Concerning the development of long-acting microparticles for biological therapeutics, SCMF processing offers several benefits over conventionally larger-scale systems such as enhanced control on fluid flow and other critical processing parameters such as pressure and temperature, easy modulation of product properties (such as particle size, morphology, and composition), cheaper equipment build-up, and convenient parallelization for high-throughput production. The objective of this project is to develop a mild microfluidic scCO2 based process for the production of long-acting injectable protein-loaded microparticles with, for example, Spider Silk Protein or PLGA as the encapsulating materials, and to evaluate the techno-economic potential of such SCMF technology for practical & industrial production.
